Cancer Type: Hematologic

For more information about any of the clinical trials listed on this site, call 314-747-7222 or 800-600-3606 toll free or email Patient_Care_Coordination_Center@bjc.org.

Select Basic Search to view clinical trials grouped by category and Advanced Search to be able to further narrow search results.

 

202003066

Evaluation of Vigamox Treatment for Ocular Graft-Versus-Host Disease

201805175

An Open-Label, Expanded Access Program of Ruxolitinib for the Treatment of Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplant

201909142

Prognostic Significance of Serial Molecular Annotation in Secondary Acute Myeloid Leukemia (sAML) in patients treated with CPX-351

201912077

A Randomized, Double-Blind, Placebo-Controlled Multicenter Phase III Trial of Alpha 1 Antitrypsin (AAT) Combined with Corticosteroids vs. Corticosteroids Alone for the Treatment of High Risk Acute Graft-versus-Host Disease (GVHD) Following Allogeneic Hematopoietic Stem Cell Transplant

202003159

A Study of Front Line Ibrutinib for Newly Diagnosed Chronic Graft-versus-Host Disease

202007059

Composite Health Assessment Model for Older Adults: Applying Pretransplant Comorbidity, Geriatric Assessment and Biomarkers to Predict Non-Relapse Mortality after Allogeneic Transplantation

202011117

Phase 1b/2a Evaluation of the Safety and Tolerability of SYN-004 in Adult Allogenic Hematopoietic Cell Transplantation Recipients